202 related articles for article (PubMed ID: 20442513)
21. Hereditary pancreatitis and secondary screening for early pancreatic cancer.
Vitone LJ; Greenhalf W; Howes NR; Neoptolemos JP
Rocz Akad Med Bialymst; 2005; 50():73-84. PubMed ID: 16358943
[TBL] [Abstract][Full Text] [Related]
22. Molecular technology and pancreatic cancer.
Manu M; Buckels J; Bramhall S
Br J Surg; 2000 Jul; 87(7):840-53. PubMed ID: 10931017
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a major gene influencing risk of pancreatic cancer.
Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.
Wescott MP; Rustgi AK
Cancer Prev Res (Phila); 2008 Dec; 1(7):503-6. PubMed ID: 19138999
[TBL] [Abstract][Full Text] [Related]
25. Familial pancreatic cancer: a review and latest advances.
Grocock CJ; Vitone LJ; Harcus MJ; Neoptolemos JP; Raraty MG; Greenhalf W
Adv Med Sci; 2007; 52():37-49. PubMed ID: 18217388
[TBL] [Abstract][Full Text] [Related]
26. Identification of high-risk pancreatic cancer-prone families.
Brand RE; Lynch HT
Gastroenterol Clin North Am; 2004 Dec; 33(4):907-18. PubMed ID: 15528025
[TBL] [Abstract][Full Text] [Related]
27. [Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people].
Gerdes B; Kress R; Rieder H; Sina-Frey M; Przypadlo E; Barth P; Rehder H; Hahn SA; Schmiegel W; Rothmund M; Ziegler A; Bartsch DK
Z Arztl Fortbild Qualitatssich; 2002 May; 96(4):251-5. PubMed ID: 12068743
[TBL] [Abstract][Full Text] [Related]
28. Familial pancreatic cancer: a review.
Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
[TBL] [Abstract][Full Text] [Related]
29. Familial pancreatic cancer (Part II): Surveillance, diagnostic tests, and surgical strategies.
Lynch HT; Fitzsimmons ML; McClellan J; Lanspa SJ; Fitzgibbons RJ; Smyrk T
Nebr Med J; 1990 Jun; 75(6):130-3. PubMed ID: 2195363
[TBL] [Abstract][Full Text] [Related]
30. Limitations in improving detection of pancreatic adenocarcinoma.
Mendieta Zerón H; García Flores JR; Romero Prieto ML
Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
[TBL] [Abstract][Full Text] [Related]
31. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
32. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
Canto MI
Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
[TBL] [Abstract][Full Text] [Related]
33. Advances in the understanding of risk factors for ovarian cancer.
Bandera CA
J Reprod Med; 2005 Jun; 50(6):399-406. PubMed ID: 16050564
[TBL] [Abstract][Full Text] [Related]
34. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259
[TBL] [Abstract][Full Text] [Related]
35. Screening of high-risk families for pancreatic cancer.
Greenhalf W; Grocock C; Harcus M; Neoptolemos J
Pancreatology; 2009; 9(3):215-22. PubMed ID: 19349734
[TBL] [Abstract][Full Text] [Related]
36. Family-based screening for colorectal cancer: The Australian perspective.
Leggett BA
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
[TBL] [Abstract][Full Text] [Related]
37. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
38. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
Chappuis PO
Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
[TBL] [Abstract][Full Text] [Related]
39. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
